Association between metabolic syndrome and carotid atherosclerosis in individuals without diabetes based on the oral glucose tolerance test

Atherosclerosis

Volumn 204, Issue 2, 2009, Pages 619-623

  Ishizaka, Nobukazu ^a   Ishizaka, Yuko ^b   Yamakado, Minoru ^b   Toda, Eiichi ^b   Koike, Kazuhiko ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Carotid artery; Glucose metabolism; Metabolic syndrome; Risk factors

Indexed keywords

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; JAPAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS;

EID: 67349125214     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.10.022     Document Type: Article

References (21)

1. Iso H., Sato S., Kitamura A., et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 38 (2007) 1744-1751
2. Kwon H.M., Kim B.J., Lee S.H., Choi S.H., Oh B.H., and Yoon B.W. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 37 (2006) 466-470
3. Wang J., Ruotsalainen S., Moilanen L., Lepisto P., Laakso M., and Kuusisto J. The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland. Stroke 39 (2008) 1078-1083
4. Fadini G.P., Coracina A., Inchiostro S., Tiengo A., Avogaro A., and de Kreutzenberg S.V. A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. Eur J Cardiovasc Prev Rehabil 15 (2008) 190-196
5. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
6. Murakami S., Otsuka K., Hotta N., et al. Common carotid intima-media thickness is predictive of all-cause and cardiovascular mortality in elderly community-dwelling people: Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) study. Biomed Pharmacother 59 Suppl 1 (2005) S49-53
7. Mannami T., Baba S., and Ogata J. Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med 160 (2000) 2297-2303
8. Ishizaka N., Ishizaka Y., Hashimoto H., et al. Metabolic syndrome may not associate with carotid plaque in subjects with optimal, normal, or high-normal blood pressure. Hypertension 48 (2006) 411-417
9. Hsu P.F., Chuang S.Y., Cheng H.M., et al. Clinical significance of the metabolic syndrome in the absence of established hypertension and diabetes: a community-based study. Diabetes Res Clin Pract 79 (2008) 461-467
10. Stern M.P., Williams K., and Hunt K.J. Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease. Atheroscler Suppl 6 (2005) 3-6
11. Ishizaka N., Ishizaka Y., Toda E., Hashimoto H., Nagai R., and Yamakado M. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis 181 (2005) 381-388
12. Ishizaka N., Ishizaka Y., Takahashi E., et al. Association between insulin resistance and carotid arteriosclerosis in subjects with normal fasting glucose and normal glucose tolerance. Arterioscler Thromb Vasc Biol 23 (2003) 295-301
13. Fowkes F.G., Murray G.D., Butcher I., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300 (2008) 197-208
14. Paras E., Mancini G.B., and Lear S.A. The relationship of three common definitions of the metabolic syndrome with sub-clinical carotid atherosclerosis. Atherosclerosis 198 (2008) 228-236
15. Vaidya D., Szklo M., Liu K., et al. Defining the metabolic syndrome construct: Multi-Ethnic Study of Atherosclerosis (MESA) cross-sectional analysis. Diabetes Care 30 (2007) 2086-2090
16. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
17. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
18. Leoncini G., Ratto E., Viazzi F., et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Intern Med 257 (2005) 454-460
19. Kawamoto R., Tomita H., Ohtsuka N., Inoue A., and Kamitani A. Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness. J Atheroscler Thromb 14 (2007) 78-85
20. Tzou W.S., Douglas P.S., Srinivasan S.R., et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol 46 (2005) 457-463
21. Pannier B., Thomas F., Bean K., et al. The metabolic syndrome: similar deleterious impact on all-cause mortality in hypertensive and normotensive subjects. J Hypertens 26 (2008) 1223-1228